Endosense appoints the company's new CFO after the company announced the close of a $40.3 million Series C funding round in late November.
Endosense names new CFO
Endosense named Nicolas Marsault as the company's new CFO. He has replaced Endosense’s previous CFO Andrea Buscaglia.
The Cather ablation technology maker won CE Mark approval in the European Union for its 3rd-generation TactiCath Quartz in June. Marsault will focus on expanding the commercial presence of the device and planning to launch the product in the U.S.